EBITDA

Riding a wave of record revenue, A10 Networks sets the stage for its Feb. 19 Investor Day, where it will detail its strategy for the AI infrastructure boom.

Veeco and Axcelis stockholders have approved their multi-billion dollar merger, but the deal's fate now rests with Chinese regulators amid high-stakes tech tensions.

Schweiter Technologies will unveil its 2025 results and 2026 strategy on Feb 27, with investors eager for signs of growth and profitability.

A new tech company just launched with an audacious goal: to unify all energy use into one intelligent, AI-driven network. But can it succeed?

A $78M loan will turn a FiDi office tower into 400+ apartments, tackling NYC's housing crisis and accelerating the area's residential transformation.

A new integration brings AI-native, end-to-end container visibility directly into Tai TMS, promising to revolutionize freight broker operations.

As AI's energy demands soar, Omni Design's new 200G co-packaged optics IP on a 3nm process promises a leap in data center efficiency and speed.

Republic Technologies taps Canadian Solar’s CFO, signaling a strategic move to blend traditional financial discipline with Web3 infrastructure development.

Amid Chapter 11 liquidation, LiDAR firm Luminar sells off key assets to pay creditors, offering to buy back senior notes at a premium.

A new bond issue strengthens Agilyx's finances, funding a dual strategy focused on immediate earnings and long-term tech licensing in plastic recycling.

With many GenAI projects failing to deliver returns, Portal26's new platform aims to turn AI investment chaos into a coherent, profitable strategy.

India's top university is planting its flag in the US, launching a new foundation to accelerate deep-tech startups and forge a transatlantic tech pipeline.

Fluent sells its Winopoly subsidiary to focus on its booming Commerce Media business, a strategic pivot aiming for long-term value amid a shifting AdTech landscape.

The CDMO giant's new independently validated system provides clients with auditable carbon data, raising the bar for sustainability in drug manufacturing.

Australian biotech Immutep reaches a key milestone in its Phase III trial for a novel lung cancer therapy, a major step in a multi-billion dollar market.

The lab automation firm is pivoting to intelligent systems, allowing scientists to create experiments with natural language to accelerate research.

With a major mine online in Korea and a new US acquisition, Almonty Industries is poised to break China's tungsten monopoly amid record prices.

As Dauch Corp, formerly American Axle, prepares its Q4 results, all eyes are on its powertrain-agnostic strategy and the integration of Dowlais Group.

Amid soaring aerospace demand and strong financials, the critical component supplier will outline its tech and market strategy at its March 10 investor day.

With rapid trial enrollment for a novel drug, Pulmovant offers a potential lifeline for patients with PH-ILD, a condition with few to no options.